Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in India
Closed Posted
- Opportunity number
- CDC-RFA-JG-26-0142
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Small Businesses
- Tribal Governments (Federally Recognized)
- Independent School Districts
- Higher Education Inst. (Public)
- 501(c)(3) Nonprofits
- City/Township Governments
- Public or Indian Housing Auth.
- Higher Education Inst. (Private)
- State Governments
- Special District Governments
- Non-501(c)(3) Nonprofits
- Tribal Organizations (Not Federally Recognized)
- For Profit Organizations
- County Governments
- Unrestricted
- Points of contact
-
- Emily Dale pepfarfoas@cdc.gov
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) is soliciting cooperative agreement applications to support India's National AIDS Control Organization (NACO), Central Tuberculosis Division (CTD), and Ministry of Health and Family Welfare to accelerate and sustain HIV and TB epidemic control, with applications due September 16, 2026. The award ceiling for Year 1 is zero; CDC anticipates $6 million total Year 1 funding, subject to availability of funds, and expects to make 1–2 awards.
Eligible applicants include small businesses, tribal governments (federally recognized), independent school districts, higher education institutions (public and private), 501(c)(3) nonprofits, city/township governments, public or Indian housing authorities, state governments, special district governments, non-501(c)(3) nonprofits, tribal organizations (not federally recognized), for-profit organizations, county governments, and unrestricted applicants, provided they conduct work in India. Local organizations must comply with India's Foreign Contribution Regulation Act (FCRA) and provide documentation of active FCRA registration.
The NOFO aligns with National AIDS Control Program (NACP) Phase VI and the National TB Elimination Program (NTEP) goals. Work takes place in India with administrative oversight through CDC partnership. Applicants must incorporate innovative, evidence-based strategies to prevent new infections, facilitate early case detection, ensure seamless linkage to care, promote treatment adherence, and achieve viral suppression. Key activities include closing gaps in HIV and TB testing and treatment, delivering integrated services for HIV and co-morbidities, strengthening program cooperation and ownership, and improving prevention, detection, and response to infectious diseases. Recipients must allocate 5–10% of funding for monitoring, evaluation, and reporting activities.
Merit review evaluates applications on Approach (40 points), Organizational Capacity (35 points), and Data, Monitoring, and Evaluation (25 points). A local organization funding preference adds 30 points for organizations meeting defined criteria. The period of performance is five years, comprising five 12-month budget periods, with expected award start date of January 1, 2027. Applicants must request funding at or below the Year 1 amount to avoid non-responsiveness.
The opportunity is listed under Assistance Listing 93.067 (Global AIDS) and 93.494 (Global Tuberculosis).
Synopsis
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $6,000,000 for Year 1, subject to the availability of funds.This NOFO supports India"s National AIDS Control Organization (NACO), Central Tuberculosis Division (CTD), and other departments in the Ministry of Health and Family Welfare (MoHFW). The goal is to enhance systems that accelerate and sustain epidemic control, in line with the National AIDS Control Program (NACP)-VI and the National TB Elimination Program (NTEP), while working to eradicate HIV and TB as public health threats.The NOFO aims to transition essential services to local ownership and foster cooperation with interest holders at all levels. To accomplish this goal you should incorporate innovative and evidence-based strategies to:• Prevent new infections.• Facilitate early case detection.• Ensure seamless linkage to care.• Promote treatment adherence.• Achieve viral suppression. Key activities include:• Closing gaps in HIV and TB testing and treatment.• Delivering integrated services for HIV and co-morbidities.• Strengthening program cooperation and ownership to enhance national efforts.• Improving prevention, detection, and response to infectious diseases.Advancing innovative HIV and TB service delivery under local leadership will create a sustainable framework for epidemic control that aligns with U.S. global health priorities, ultimately saving lives and bolstering global health security.
Files
| File | Type | Posted |
|---|---|---|
| cdc-rfa-jg-26-0142_v6_for posting.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity